US Neurosurgical Holding (US Neurosurgical Holding) Total Assets : $2.60 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is US Neurosurgical Holding Total Assets?

US Neurosurgical Holding's Total Assets for the quarter that ended in Mar. 2024 was $2.60 Mil.

During the past 12 months, US Neurosurgical Holding's average Total Assets Growth Rate was 177.80% per year. During the past 3 years, the average Total Assets Growth Rate was -19.00% per year. During the past 5 years, the average Total Assets Growth Rate was -35.50% per year. During the past 10 years, the average Total Assets Growth Rate was -22.80% per year.

During the past 13 years, US Neurosurgical Holding's highest 3-Year average Total Assets Growth Rate was 28.00%. The lowest was -57.70%. And the median was -6.50%.

Total Assets is connected with ROA %. US Neurosurgical Holding's annualized ROA % for the quarter that ended in Mar. 2024 was -63.66%. Total Assets is also linked to Revenue through Asset Turnover. US Neurosurgical Holding's Asset Turnover for the quarter that ended in Mar. 2024 was 0.00.

US Neurosurgical Holding Total Assets Historical Data

The historical data trend for US Neurosurgical Holding's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Neurosurgical Holding Total Assets Chart

US Neurosurgical Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

5.00

4.17

3.69

1.75

1.32

US Neurosurgical Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															1.59	1.01	0.87	1.32	2.60

US Neurosurgical Holding Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

US Neurosurgical Holding's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	0.645	+	0.676
	=	1.32

US Neurosurgical Holding's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	0.333	+	2.267
	=	2.60

US Neurosurgical Holding (OTCPK:USNU) Total Assets Explanation

Total Assets is connected with ROA %.

US Neurosurgical Holding's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-1.248	/	( (1.321	+	2.6)	/ 2 )
	=	-1.248	/	1.9605
	=	-63.66 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

US Neurosurgical Holding's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0	/	( (1.321	+	2.6)	/ 2 )
=	0	/	1.9605
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

US Neurosurgical Holding Total Assets Related Terms

Thank you for viewing the detailed overview of US Neurosurgical Holding's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

US Neurosurgical Holding (US Neurosurgical Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Neurosurgical Holding Inc (OTCPK:USNU) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2400 Research Boulevard, Suite 325, Rockville, MD, USA, 20850

Website

http://www.usneuro.com

US Neurosurgical Holding Inc operates as a holding company in United State. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.

Executives

Lawrence William St	director	23 ASHLAND STREET, NEWBURYPORT MA 01950-1905
William F. Leimkuhler	director	43 SALEM STRAITS RD, DARIEN CT 06820
Merriman Charles H Iii	director
Alan Gold	director, 10 percent owner, officer: President & Chairman	2400 RESEARCH BLVD, SUITE 325, ROCKVILLE MD 20850
Stanley S Shuman	10 percent owner	C/O RIPPLEWOOD HOLDINGS LLC, ONE ROCKERFELLER PLAZA, NEW YORK NY 10020
Allen & Co Inc	10 percent owner	711 FIFTH AVENUE, NEW YORK NY 10022

US Neurosurgical Holding (US Neurosurgical Holding) Headlines

No Headlines